Alnylam Pharmaceuticals, Inc.

OXLUMO lumasiran Brochure

The first and only FDA-approved prescription medication for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine

Most popular related searches

Contact supplier

Drop file here or browse